Comparison of SP263 and 22C3 pharmDx assays to test programmed death ligand-1 (PD-L1) expression in surgically resected non-small cell lung cancer.

Shigeta N, Murakami S, Yokose T, Isaka T, Shinada K, Nagashima T, Adachi H, Shigefuku S, Murakami K, Miura J, Kikunishi N, Watabe K, Saito H, Ito H

Open source

DOI
10.1111/1759-7714.15319
Published
2024 Jun
Container
Thoracic cancer
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/1759-7714.15319,
  title = {Comparison of SP263 and 22C3 pharmDx assays to test programmed death ligand-1 (PD-L1) expression in surgically resected non-small cell lung cancer.},
  author = {Shigeta N and Murakami S and Yokose T and Isaka T and Shinada K and Nagashima T and Adachi H and Shigefuku S and Murakami K and Miura J and Kikunishi N and Watabe K and Saito H and Ito H},
  year = {2024},
  journal = {Thoracic cancer},
  doi = {10.1111/1759-7714.15319},
  url = {https://doi.org/10.1111/1759-7714.15319}
}

RIS

TY  - JOUR
TI  - Comparison of SP263 and 22C3 pharmDx assays to test programmed death ligand-1 (PD-L1) expression in surgically resected non-small cell lung cancer.
AU  - Shigeta N
AU  - Murakami S
AU  - Yokose T
AU  - Isaka T
AU  - Shinada K
AU  - Nagashima T
AU  - Adachi H
AU  - Shigefuku S
AU  - Murakami K
AU  - Miura J
AU  - Kikunishi N
AU  - Watabe K
AU  - Saito H
AU  - Ito H
PY  - 2024
JO  - Thoracic cancer
DO  - 10.1111/1759-7714.15319
UR  - https://doi.org/10.1111/1759-7714.15319
ER  - 

APA

N, S., S, M., T, Y., T, I., K, S., T, N., H, A., S, S., K, M., J, M., N, K., K, W., H, S., & H, I. (2024). Comparison of SP263 and 22C3 pharmDx assays to test programmed death ligand-1 (PD-L1) expression in surgically resected non-small cell lung cancer.. Thoracic cancer. https://doi.org/10.1111/1759-7714.15319

Source records